SCHEMBL1840723

SCHEMBL1840723

COC(=O)c1ccc(OCC(C2CCCCC2)C2(c3ccc(Cl)cc3)Nc3cc(F)c(F)cc3N2)c(C(F)(F)F)c1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 2/20 0.42
NR1H4 Q96RI1 2/20 0.35
CYP3A4 P08684 1/20 0.34
ESRRA P11474 1/20 0.34
CNR2 P34972 2/20 0.34
S1PR3 Q99500 1/20 0.33
TAS1R3 Q7RTX0 2/20 0.33
TAS1R1 Q7RTX1 2/20 0.33
TAS1R2 Q8TE23 2/20 0.33
DDR1 Q08345 2/20 0.33
EPHX2 P34913 1/20 0.33
SCN9A Q15858 1/20 0.33
NOTUM Q6P988 1/20 0.32
MCHR1 Q99705 1/20 0.32
PTGDR Q13258 1/20 0.32
PTGDR2 Q9Y5Y4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1840000 0.91 NR1H4 (0.41) MRGPRX4NR1H4CYP3A4TAS1R3TAS1R1
SCHEMBL1840310 0.91 NR1H4 (0.36) NR1H4CYP3A4PTGDRPTGDR2
SCHEMBL1842692 0.91 NPC1 (0.37) MRGPRX4NR1H4CYP3A4TAS1R3TAS1R1
SCHEMBL1838564 0.90 SMN1; SMN2 (0.38) NR1H4CYP3A4TAS1R3TAS1R1PTGDR
SCHEMBL1840826 0.86 ACKR3 (0.34) MRGPRX4NR1H4PTGDRPTGDR2
SCHEMBL1843050 0.85 NR1H4 (0.33) NR1H4CYP3A4PTGDRPTGDR2
SCHEMBL1839912 0.85 NR1H4 (0.33) NR1H4CYP3A4PTGDRPTGDR2
SCHEMBL1842541 0.83 GABRA5 (0.38) NR1H4
SCHEMBL1841658 0.83 GABRA5 (0.38) NR1H4
SCHEMBL1837376 0.83 PROKR1 (0.36) NR1H4CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2321282-A1 NEW BENZIMIDAZOLE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2011-05-18 EP disclosed
WO-2010028981-A1 NEW BENZIMIDAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2010-03-18 WO disclosed